Optimizing your clinical development strategy from trial design through regulatory approval depends on access to the right data sources structured for your specific use case. Understanding disease natural history, identifying optimal patient populations, benchmarking against real-world treatment patterns, and creating synthetic control arms for rare disease studies all require careful alignment between your objectives and the available data landscape. The challenge most organizations face is not finding data providers—it is determining which combination of coverage, analytical capabilities, and domain expertise matches their clinical priorities. Expert advisory guidance closes that gap.